BCHE and Parkinson disease: Nowadays, conventional pharmacotherapies for neurological conditions—such as cholinesterase inhibitors for Alzheimer’s or Ldopa for Parkinson’s—often provide limited symptom relief, exhibit side effects, and fail to halt disease w, underscoring the need for alternative strategies.